Report Industry Investment Rating No relevant content provided. Core Viewpoints of the Report - This week, the public REITs market fluctuated. The trading volume of the REITs market increased, and the indices of equity - type and concession - type public REITs showed differentiation. Most public REITs products rose. There are 24 public REITs funds waiting to be listed, and the market is expected to continue to expand. In the context of asset shortage, public REITs have the advantages of high dividends and medium - low risks, with a relatively high cost - performance ratio for allocation [2][5][38] Summary by Directory 1. Secondary Market: This Week, the Public REITs Market Fluctuated - **Index Performance**: As of October 31, 2025, the China Securities REITs Index fell 0.14% from last week to 814.9, while the China Securities REITs Total Return Index rose 0.16% from last week to 1045.73 [10] - **Trading Volume and Turnover**: The total trading volume of the REITs market this week was 784 million shares, a 24.44% week - on - week increase, and the trading amount was 3.303 billion yuan, a 21.48% week - on - week increase. The market's interval turnover rate was 3.19%, compared with 2.59% last week [11] - **Index Differentiation by Asset Type**: The equity - type public REITs index rose 1.82%, and the concession - type public REITs index fell 0.13%. Among equity - type REITs, new infrastructure, affordable rental housing, and consumer infrastructure REITs rose 3.13%, 2.09%, and 1.99% respectively, while warehousing and logistics, and park infrastructure REITs fell 0.24% and 0.21% respectively. Among concession - type public REITs, municipal facilities, water conservancy facilities, and ecological and environmental protection REITs rose 2.38%, 0.60%, and 0.50% respectively, while transportation infrastructure and energy infrastructure REITs fell 0.34% and 0.12% respectively [13][17] - **Trading Volume and Turnover Rate by Type**: Most types of public REITs saw an increase in trading volume. The trading volume of municipal facilities, consumer infrastructure, new infrastructure, ecological and environmental protection, warehousing and logistics, affordable rental housing, park infrastructure, and transportation infrastructure REITs increased by 308.33%, 50.47%, 44.41%, 36.98%, 30.76%, 28.78%, 27.26%, and 0.58% respectively week - on - week. The trading volume of water conservancy facilities and energy infrastructure REITs decreased by 24.11% and 19.17% respectively. In terms of turnover rate, the daily average turnover rates of new infrastructure and affordable rental housing REITs were greater than 1. The daily average turnover rates of most types of REITs increased, while those of water conservancy facilities and energy infrastructure REITs decreased [21] - **Single - Target Performance**: Among the 76 public REITs (excluding the newly listed Huaxia Zhonghai Commercial Asset REIT), 48 rose and 27 fell. The top gainers were Chuangjin Hexin Shounong REIT, Southern Wanguo Data Center REIT, and CICC Yinli Consumer Infrastructure REIT, with weekly gains of 4.2%, 4.1%, and 3.9% respectively. The top losers were Huaxia Hefei High - tech Industrial Park REIT, China Merchants Science and Technology Incubator REIT, and E Fund Guangzhou Development Zone High - tech Industrial Park REIT, with weekly losses of 7.8%, 4.7%, and 4.2% respectively [22] 2. Primary Market: 24 Public REITs Funds are Waiting to be Listed - **Issuance in 2025**: As of October 31, 2025, a total of 77 public REITs have been issued, with a total issuance scale of 198.1 billion yuan. In 2024, 29 REITs were issued, with a total scale of 64.6 billion yuan. Since 2025, 18 public REITs have been issued, and 2 new public REITs were issued in October 2025 [28] - **Pending Listings**: As of October 31, 2025, there are 24 public REITs funds waiting to be listed, including 11 initial offerings and 13 follow - on offerings. In terms of project status, 11 have passed, 6 have been feedbacked, 4 have been questioned, 2 have been accepted, and 1 has been declared. By type, among industrial REITs, there are 6 park - type REITs, 2 consumer infrastructure REITs, 4 warehousing and logistics REITs, and 5 affordable rental housing REITs; among concession - type REITs, there are 3 energy - type REITs, 2 transportation - type REITs, and 1 ecological and environmental protection REIT [30] 3. Public REITs Policies and Market Dynamics - **Policy Support for Commercial Real Estate REITs**: On October 29, the General Offices of 5 departments including the Ministry of Commerce issued the "Urban Commercial Quality Improvement Action Plan", which supports eligible commercial real estate projects to issue REITs [33] - **Approval of Huaxia Fund China Resources Youchao REIT's Follow - on Offering**: On October 29, the status of Huaxia Fund China Resources Youchao Rental Housing Closed - end Infrastructure Securities Investment Fund on the Shanghai Stock Exchange was updated to "approved" [35] - **Tianjin's Support for REITs in High - tech and Innovation Parks**: On October 31, 11 departments in Tianjin issued a notice on the "Special Plan for Financial Innovation Services for Scientific and Technological Innovation and Industrial Innovation", which supports high - tech and strategic emerging industry enterprises to issue bonds for financing and supports the issuance of REITs in new infrastructure and eligible science and technology innovation industrial parks [36] 4. Investment Suggestions - **Index and Market Performance**: This week, the REITs index fluctuated. The China Securities REITs Index fell 0.14% from last week, and the China Securities REITs Total Return Index rose 0.06% from last week. The trading amount in the public REITs market increased. By asset type, the equity - type public REITs index rose 1.82%, and the concession - type public REITs index fell 0.13%, with new infrastructure REITs having the highest increase and transportation infrastructure REITs having the highest decrease [37] - **Market Expansion and Investment Value**: This Wednesday, Huaxia Fund China Resources Youchao REIT's follow - on offering application was approved by the Shanghai Stock Exchange. This Friday, Huaxia Zhonghai Commercial REIT was listed. Since this year, 18 public REITs have been issued, with a total scale of over 30 billion yuan. In addition, 24 REITs funds are waiting to be listed, and the market is expected to continue to expand. In the context of asset shortage, public REITs have high dividends and medium - low risks, with a relatively high cost - performance ratio for allocation [38]

Investment Rating - The report assigns a rating of "Accumulate" for the company [1][8] Core Views - The company has shown steady revenue growth, with a 3.73% year-on-year increase in revenue to 9.607 billion yuan for the first three quarters of 2025, and a 6.87% increase in net profit to 4.240 billion yuan [3][4] - The growth in revenue is primarily driven by increased investment from internet clients, particularly in building media advertising, which saw an 88.82% year-on-year increase [4] - The acquisition of New Wave Media for 8.3 billion yuan is expected to enhance the company's media point coverage and drive future revenue growth [5] - The launch of the "Tap to Grab Red Packet" service in collaboration with Alipay is anticipated to bring in new customers and improve operational efficiency [5] - The company has a strong commitment to returning value to shareholders, with a planned cash dividend of 0.50 yuan per share, totaling 7.22 billion yuan for Q3 2025 [6] Financial Performance - For Q3 2025, the company reported revenue of 3.494 billion yuan, a 6.08% increase year-on-year, and a net profit of 1.576 billion yuan, up 6.85% [3][4] - The gross margin improved to 70.4%, reflecting a 4.18 percentage point increase year-on-year, driven by optimization of media points [4] - The company expects revenue for 2025 to reach 13.02 billion yuan, with a growth rate of 6.14%, and net profit to be 5.61 billion yuan, reflecting an 8.82% growth [10][8] Future Outlook - The company anticipates continued growth in revenue and net profit through 2027, with projected revenues of 13.83 billion yuan and 14.71 billion yuan for 2026 and 2027, respectively [10][8] - The expected net profit for 2026 and 2027 is projected to be 6.00 billion yuan and 6.41 billion yuan, respectively, with growth rates of 6.96% and 6.86% [10][8]

Investment Rating - The report maintains a "Buy" rating for the company with a target price based on the last closing price of 38.17 [1][8] Core Insights - The company reported a revenue of 110.6 billion yuan for the first three quarters of 2025, representing a year-on-year increase of 20.1%, and a net profit attributable to shareholders of 6.7 billion yuan, up 11.2% year-on-year [3][4] - The third quarter revenue reached 38.9 billion yuan, a year-on-year increase of 27.4%, with a net profit of 2.3 billion yuan, reflecting a 14.5% year-on-year growth [4] - The gross margin for Q3 was 19.4%, showing an improvement of 1.6 percentage points year-on-year [4] Revenue Growth and Business Expansion - The digital energy segment achieved a revenue of 10.27 billion yuan in 2024, growing by 47.44% year-on-year, contributing 8.08% to total revenue [5] - The company is focusing on liquid cooling technology for data centers and energy storage systems, which is expected to drive significant growth in the coming years [5] - The humanoid robot business is anticipated to lead a new growth curve, with strategic partnerships and a focus on core technology development [6] Financial Projections - Revenue projections for 2025, 2026, and 2027 are 157 billion yuan, 187 billion yuan, and 215 billion yuan respectively, with net profits of 9.5 billion yuan, 12 billion yuan, and 15.8 billion yuan [8] - The projected price-to-earnings ratios for the same years are 34, 27, and 20 respectively [8] Global Operations and Manufacturing - The company has established production bases in North America, Mexico, Poland, Malaysia, India, and Sweden, enhancing its global manufacturing capabilities [7] - The North American segment reported revenue of approximately 788.3 million yuan in the first half of the year, with a net profit of 34.4 million yuan [7] Strategic Initiatives - The company has implemented a "1+4+N" strategy for humanoid robots, aiming for significant breakthroughs in key customer collaborations [6] - The establishment of a dedicated AI product department is focused on advancing core technologies and building foundational technology reserves [6]

Investment Rating - The report maintains a "Buy" rating for the company [1][8] Core Insights - The company reported a significant revenue growth of 39.79% year-on-year, reaching 584 million yuan for the first three quarters of 2025, with a net profit increase of 68.68% to 104 million yuan [4][8] - In Q3 2025, the company achieved a revenue of 227 million yuan, marking a 61.66% increase year-on-year, and a net profit of 49 million yuan, which is a remarkable growth of 205.50% [4][8] - The growth in revenue is attributed to accelerated industry procurement and an increase in market share, particularly in equipment sales and self-produced consumables [4][5] Summary by Sections Financial Performance - For the first three quarters of 2025, the company’s gross margin increased by 0.98 percentage points to 48.52% [7] - The company’s self-produced consumables revenue reached 65 million yuan in the first half of 2025, a year-on-year increase of 91.90% [6] - The projected revenues for 2025-2027 are 797 million, 1,015 million, and 1,264 million yuan, with corresponding net profits of 160 million, 209 million, and 267 million yuan, indicating growth rates of 125.81%, 30.51%, and 27.69% respectively [8][11] Market Position - As of September 2025, the company holds a market share of 21.74% in the blood dialysis machine sector, ranking first in the industry [5] - The company’s market share for Continuous Renal Replacement Therapy (CRRT) is 18%, maintaining its leading position [5] Future Outlook - The company is expected to continue its growth trajectory, with revenue forecasts showing a compound annual growth rate (CAGR) of 40.50% for 2025 [8][11] - The earnings per share (EPS) are projected to increase from 0.50 yuan in 2025 to 0.83 yuan in 2027, reflecting a positive outlook for profitability [8][11]

Investment Rating - The investment rating for the company is "Buy" with a target price based on the last closing price of 7.41 [1][4]. Core Insights - The company has shown growth in its pig farming business while reducing costs, and its feed sales continue to grow [1][4]. - For the first three quarters of 2025, the company achieved revenue of 13.61 billion, a year-on-year increase of 4%, but the net profit attributable to shareholders decreased by 27.2% to 411 million [3][4]. - The company expects further cost optimization in production efficiency and other expenses [3]. Revenue and Profitability - In Q3 2025, the company reported revenue of 4.764 billion, a decline of 6.49% year-on-year, with a net profit of 73.46 million, down 74.58% [3]. - The total number of pigs sold in the first three quarters was 2.2823 million, an increase of 6.46% year-on-year [3]. - The comprehensive cost of pig farming in Q3 was 12.78 yuan/kg, down from 13 yuan/kg in the first half of the year [3]. Feed Business Performance - The feed business achieved sales of 2.12 million tons in the first three quarters, a year-on-year increase of 3.62%, with Q3 sales reaching 776,000 tons, up 11.8% [4]. - Pig feed sales increased by 18% to 462,300 tons, while poultry feed sales grew by 8% to 165,500 tons [4]. Profit Forecast and Investment Recommendations - Due to the anticipated decline in pig prices, the profit forecasts for 2025 and 2026 have been lowered, with expected net profits of 585 million and 979 million respectively [4]. - The earnings per share (EPS) are projected to be 0.43 yuan for 2025 and 0.72 yuan for 2026, with corresponding price-to-earnings (PE) ratios of 17.23x and 10.29x [4].

Investment Rating - The report maintains a "Buy" rating for the company, with a target price based on the last closing price of 21.35 [1] Core Insights - The company reported a revenue of 25.44 billion yuan for the first three quarters of 2025, representing a year-on-year increase of 13.50%. The net profit attributable to shareholders reached 3.62 billion yuan, up 45.64% year-on-year. In the third quarter alone, revenue was 8.37 billion yuan, a 1.44% increase year-on-year, with a net profit of 1.06 billion yuan, reflecting a 23.02% year-on-year growth [4][5] - The traditional livestock and poultry health business continues to grow steadily, with an optimized product structure. The pet health segment is gradually building ecological advantages. The company is also actively expanding into the ruminant vaccine market through a joint venture with Shengwei Biological, focusing on the development and production of vaccines for cattle and sheep [5] - The company is entering the microbial protein industry, which is expected to contribute to new revenue streams. A project for the industrialization of microbial protein with a total investment of 679 million yuan is underway, with 296 million yuan raised for this purpose. This strategic move aims to extend the company's business from animal health to broader high-quality protein solutions [5] Financial Summary - The company is projected to achieve revenues of 35.29 billion yuan, 38.82 billion yuan, and 42.71 billion yuan for the years 2025, 2026, and 2027, respectively. The net profit attributable to shareholders is expected to be 4.74 billion yuan, 5.03 billion yuan, and 5.49 billion yuan for the same years. Corresponding price-to-earnings ratios (PE) are forecasted to be 22.27, 20.06, and 18.36 [6][7] - The financial indicators show a gross margin of 45.00% for 2025, with a net profit margin of 13.43%. The revenue growth rate is expected to be 14.97% for 2025, with a net profit growth rate of 57.64% [9]

Investment Rating - The report maintains an "Accumulate" rating for Wuliangye [1] Core Views - Wuliangye is experiencing short-term pressure due to proactive adjustments, aiming for a balance between volume and price while waiting for market recovery [5] - The company reported a total revenue of 60.945 billion yuan for Q1-Q3 2025, a year-on-year decrease of 10.26%, and a net profit attributable to shareholders of 21.511 billion yuan, down 13.72% year-on-year [4][6] - In Q3 2025, the company achieved a total revenue of 8.174 billion yuan, a significant decline of 52.66% year-on-year, with a net profit of 2.019 billion yuan, down 65.62% year-on-year [4][6] Financial Performance - For Q1-Q3 2025, the gross profit margin was 74.9%, a decrease of 2.1 percentage points year-on-year, while Q3 2025 saw a gross profit margin of 62.6%, down 13.5 percentage points year-on-year [6] - The company’s net profit margin for Q1-Q3 2025 was 35.3%, down 1.4 percentage points year-on-year, with Q3 2025 net profit margin at 24.7%, down 9.3 percentage points year-on-year [6] - The company plans to distribute a cash dividend of 25.78 yuan per 10 shares (before tax), totaling 10.007 billion yuan, reflecting a mid-term dividend yield of 2.17% [4] Revenue and Profit Forecast - Revenue growth rates for 2025-2027 are projected at -15.0%, 0.0%, and 4.0%, respectively, while net profit growth rates are expected to be -16.2%, 2.0%, and 4.3% [7] - The estimated earnings per share (EPS) for 2025-2027 are 6.88 yuan, 7.01 yuan, and 7.32 yuan, respectively, corresponding to a price-to-earnings (PE) ratio of 17x for 2025 and 16x for 2026 and 2027 [7][9] Market Position and Strategy - The company is actively optimizing channel inventory and stabilizing product prices to maintain long-term brand value, despite short-term impacts on financial statements [5] - A new product, "29° Wuliangye·First Encounter," targeting younger consumers, has achieved over 100 million yuan in sales within two months of its launch [5]

Investment Rating - The report maintains a "Buy" rating for the company KQ Bio (688526) with a target price based on the last closing price of 16.15 [1] Core Insights - The company's net profit margin continues to improve, with a focus on the upcoming new product launches [1][5] - For the first three quarters of 2025, the company achieved a revenue of 738 million yuan, a year-on-year increase of 10.87%, and a net profit of 338 million yuan, a year-on-year increase of 29.62% [4][5] - The third quarter of 2025 saw a revenue of 251 million yuan, a year-on-year decrease of 5.44%, but a net profit increase of 9.17% to 118 million yuan [4][5] Financial Performance - The gross margin for the first three quarters of 2025 was 66.96%, an increase of 2.95% year-on-year, while the net margin was 45.62%, up by 6.55% year-on-year [5] - The company has increased its R&D investment, spending 71.87 million yuan in the first three quarters of 2025, which is 9.74% of its revenue, marking a 17.5% year-on-year increase [5] - The company has received several new veterinary drug registration certificates, indicating ongoing product development and potential for long-term growth [5] Earnings Forecast and Valuation - The company is expected to achieve revenues of 1.13 billion yuan, 1.41 billion yuan, and 1.68 billion yuan for 2025, 2026, and 2027 respectively, with corresponding net profits of 460 million yuan, 618 million yuan, and 741 million yuan [6][7] - The projected price-to-earnings (PE) ratios for 2025, 2026, and 2027 are 17.55, 13.06, and 10.89 respectively, supporting the "Buy" rating [6][7]

Investment Rating - The report maintains a "Buy" rating for TCL Smart Home (002668) with a target price based on the last closing price of 10.35 [1][6]. Core Insights - TCL Smart Home reported a revenue of 143.46 billion yuan for the first three quarters of 2025, reflecting a growth of 2.87%, and a net profit attributable to shareholders of 9.77 billion yuan, which is an increase of 18.45% [4][5]. - The company's Q3 2025 revenue was 48.69 billion yuan, down 2.30% year-on-year, attributed to external uncertainties such as tariffs. However, the global strategy is expected to drive growth, particularly in overseas markets like the Middle East, Africa, and Latin America [5]. - The net profit for Q3 2025 was 3.39 billion yuan, showing a significant increase of 27.51%, benefiting from the launch of high-end new products and improved production efficiency [5][6]. Financial Performance Summary - For Q3 2025, the gross profit margin was 27.16%, up 3.12 percentage points, driven by the introduction of high-margin products such as the "Ice Kirin" refrigerator and "AI Super Tube" washing machine [5]. - The net profit margin for Q3 2025 was 13.21%, an increase of 3.02 percentage points, indicating improved profitability [5]. - The report forecasts net profits for 2025, 2026, and 2027 to be 12.03 billion yuan, 13.34 billion yuan, and 14.59 billion yuan respectively, with corresponding EPS of 1.11 yuan, 1.23 yuan, and 1.35 yuan [6][7].

Investment Rating - The report maintains a "Buy" rating for Midea Group (000333) with a target price based on the last closing price of 75.30 [1] Core Insights - Midea Group's Q3 performance shows a high single-digit growth, with total revenue for the first three quarters reaching 364.716 billion yuan, up 13.85% year-on-year, and net profit attributable to shareholders at 37.883 billion yuan, up 19.51% [4][5] - The company emphasizes its OBM (Original Brand Manufacturing) and robotics strategy, which is expected to empower its long-term growth in both home appliances and industrial manufacturing [5] Financial Performance - In Q3 2025, Midea Group achieved total revenue of 112.385 billion yuan, reflecting a 9.94% increase, and net profit of 11.870 billion yuan, up 8.95% [5] - For the first three quarters, the ToC (To Consumer) and ToB (To Business) business segments reported revenue growth of 13% and 18% respectively, with OBM revenue accounting for over 45% of ToC overseas revenue [5] - The company's gross margin in Q3 was 26.44%, an increase of 0.40 percentage points, attributed to improved product mix [6] Business Segments - The revenue from the B2B segment, including new energy and industrial technology, smart building technology, and robotics and automation, was 30.6 billion yuan, 28.1 billion yuan, and 22.6 billion yuan respectively, with year-on-year growth rates of 21%, 25%, and 9% [5] - The report highlights the strong performance of high-end brands COLMO and Toshiba in the consumer segment [5] Future Outlook - The report projects Midea Group's net profit for 2025-2027 to be 44.864 billion yuan, 49.106 billion yuan, and 53.018 billion yuan respectively, with corresponding EPS of 5.84 yuan, 6.39 yuan, and 6.90 yuan [6][8] - The current stock price corresponds to a PE ratio of 12.90 for 2025, 11.78 for 2026, and 10.91 for 2027, indicating potential for growth [6][8]